Assessing Breast Cancer Margins Ex Vivo Using Aqueous Quantum-Dot-Molecular Probes
Figure 8
Interference examination of AQD-Tn mAb probe on standard pathological evaluations. (a) Control tumors; (b) AQD-treated tumors. Different markers were evaluated such as Tn antigen, p53, and ki67. No interference with the following pathological examination was found.
